Para and Amniotic cavity infection - a phase IV clinical study of FDA data

Summary:

Amniotic cavity infection is reported only by a few people who take Para.

The phase IV clinical study analyzes which people take Para and have Amniotic cavity infection. It is created by eHealthMe based on reports of 1,772 people who have side effects while taking Para from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 16, 2022

1,772 people reported to have side effects when taking Para.
Among them, 4 people (0.23%) have Amniotic cavity infection.


What is Para?

Para has active ingredients of para - aminobenzoic acid (paba). eHealthMe is studying from 1,780 Para users for its effectiveness, alternative drugs and more.

What is Amniotic cavity infection?

Amniotic cavity infection is found to be associated with 238 drugs and 135 conditions by eHealthMe.

Number of Para and Amniotic cavity infection reports submitted per year:

Could Para cause Amniotic cavity infection?

Age of people who have Amniotic cavity infection when taking Para *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 100 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Para *:

  1. Vitamin C: 4 people, 100.00%
  2. Glucosamine: 4 people, 100.00%
  3. Fish Oil: 4 people, 100.00%
  4. Asacol: 4 people, 100.00%
  5. Turmeric: 3 people, 75.00%
  6. Prednisone: 1 person, 25.00%
  7. Calcium Carbonate: 1 person, 25.00%

Common side effects people have besides Amniotic cavity infection *:

  1. Maternal Exposure During Pregnancy (use of substance during pregnancy): 4 people, 100.00%
  2. Joint Pain: 4 people, 100.00%
  3. Drowsiness: 4 people, 100.00%
  4. Drug Level Above Therapeutic: 4 people, 100.00%
  5. Fatigue (feeling of tiredness): 4 people, 100.00%
  6. Fever: 4 people, 100.00%
  7. Breech Delivery (delivery of an infant whose feet or buttocks appear first): 4 people, 100.00%
  8. Oxygen Saturation Decreased: 4 people, 100.00%
  9. Premature Rupture Of Membranes: 4 people, 100.00%
  10. Rectal Haemorrhage (bleeding from anus): 4 people, 100.00%

Common conditions people have *:

  1. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Para and have Amniotic cavity infection?

Check whether Amniotic cavity infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Amniotic cavity infection and when was it recovered:

Expand to all the drugs that have ingredients of para - aminobenzoic acid (paba):

Alternative drugs to, pros and cons of Para:

  • Para (1,780 reports)

Amniotic cavity infection treatments and more:

COVID vaccines that are related to Amniotic cavity infection:

All the drugs that are associated with Amniotic cavity infection:

All the conditions that are associated with Amniotic cavity infection:

How the study uses the data?

The study uses data from the FDA. It is based on para - aminobenzoic acid (paba) (the active ingredients of Para) and Para (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: